Limited Competition: Alzheimer's Disease Cooperative Study (U19)
The summary for the Limited Competition: Alzheimer's Disease Cooperative Study (U19) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Alzheimer's Disease Cooperative Study (U19): This limited competition FOA is to continue the Alzheimer's Disease Cooperative Study (ADCS) as the pre-eminent Alzheimer's disease (AD) clinical trials consortium. The purpose of this FOA is to solicit the renewal application for the next 5-year cycle of the ADCS. The goals of this next phase are to continue to advance research in the development of interventions that might be useful for treating, delaying, or preventing AD, particularly interventions that might not be developed by industry.
Federal Grant Title: | Limited Competition: Alzheimer's Disease Cooperative Study (U19) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AG-13-001 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.866 |
CFDA Descriptions: | Aging Research |
Current Application Deadline: | Mar 07, 2012 |
Original Application Deadline: | Mar 07, 2012 |
Posted Date: | November 28th, 2011 |
Creation Date: | Nov 28, 2011 |
Archive Date: | Apr 07, 2012 |
Total Program Funding: | $13,000,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
- • Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allow...
- • Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (...
- • Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumul...
- • Research Training in Aging for Medical Students (T35)
- • Technological Enhancements and Archiving for Surveys of the Elderly: SBIR (R43/44) Initiat...
- • Technological Enhancements and Archiving for Surveys of the Elderly: STTR (R41/42) Initiat...
- • Technology and Aging: NIA Small Business Technology Transfer Program Initiative (STTR [R41...
- More Grants from the National Institutes of Health
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
- • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...